Piramal Pharma Limited (PPLPHARMA.NS)

INR 260.5

(-1.59%)

Market Cap (In INR)

345.35 Billion

Revenue (In INR)

81.71 Billion

Net Income (In INR)

178.2 Million

Avg. Volume

8.14 Million

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
114.35-307.9
PE
-
EPS
-
Beta Value
0.084
ISIN
INE0DK501011
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Peter Daniel DeYoung
Employee Count
-
Website
https://www.piramal.com/businesses/piramal-pharma/
Ipo Date
2022-10-19
Details
Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.

More Stocks